UK PM to urge speedy adoption of flexible drug licensing in EU
This article was originally published in Scrip
Executive Summary
UK prime minister David Cameron plans to press the case for "less red tape" in the EU when he attends next week's European Council meeting, and will among other things call for the introduction of more flexible drug approval procedures and the rapid adoption of the draft EU clinical trials Regulation to help overcome barriers to innovation.